Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan · Delayed Price · Currency is TWD 43.50
+0.40 (0.93%)
Apr 29, 2026, 1:30 PM CST
TPEX:4160 Market Cap
TPEX:4160 has a market cap or net worth of 1.15 billion as of April 28, 2026. Its market cap has decreased by -33.38% in one year.
Market Cap
1.15B
Enterprise Value
821.04M
Revenue
603.11M
Ranking
n/a
PE Ratio
53.88
Stock Price
43.50
Market Cap Chart
Since July 15, 2011, TPEX:4160's market cap has increased from 957.80M to 1.15B, an increase of 20.10%. That is a compound annual growth rate of 1.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 1.15B | -13.45% |
| Dec 31, 2025 | 1.33B | -27.41% |
| Dec 31, 2024 | 1.83B | 85.27% |
| Dec 29, 2023 | 988.25M | 48.75% |
| Dec 30, 2022 | 664.37M | 10.48% |
| Dec 30, 2021 | 601.33M | 0.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.82B |
| DIVA Laboratories | 1.78B |
| Kim Forest Enterprise | 788.11M |
| TFBS Bioscience | 731.98M |
| Sofiva Genomics | 708.26M |
| Puriblood Medical | 707.23M |
| Pharmigene | 499.60M |
| Welgene Biotech | 426.47M |